Global Market Study on Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers: MEA Regional Market Anticipated to Witness 1.6X Growth over the Forecast Period


Surgical Hemostat Internal Tissue Sealant Adhesion Barrier Market
  • Published On : Jan-2017 |
  • Pages : 190 Pages |
  • Format :

Persistence Market Research presents an exhaustive report on the global surgical hemostats, internal tissue sealants and adhesion barriers market in a new publication titled “Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers Market: Global Industry Analysis and Forecast, 2016–2024.”  The report frames a bird’s eye view of the global surgical hemostats, internal tissue sealants and adhesion barriers market and also explains the regional market psyche and talks about all the major segments of the global surgical hemostats, internal tissue sealants and adhesion barriers market. The report vividly analyses the opportunities available to all the companies operating in the global surgical hemostats, internal tissue sealants and adhesion barriers market. The study has focused on different developments that are anticipated to change the face of the global surgical hemostats, internal tissue sealants and adhesion barriers market. A dedicated team of Persistence Market Research analysts worked extensively to understand the drivers, restraints and trends that are predicted to influence the future of the global surgical hemostats, internal tissue sealants and adhesion barriers market and also the day-to-day business operations of the key players operating in this market. Through in-depth research, the analysts have rightly projected the impending effects of market dynamics on the current and future climate of the global surgical hemostats, internal tissue sealants and adhesion barriers market. The evolving dynamics of the market is predicted to impact the future business plans and expansion strategies of the mid-level and large-scale market players.

Report structure

  • The executive summary, definitions and overview of the global surgical hemostats, internal tissue sealants and adhesion barriers market provides a 360-degree view of the revenue forecast of the global surgical hemostats, internal tissue sealants and adhesion barriers market.
  • In the taxonomy section, the report divides the entire global surgical hemostats, internal tissue sealants and adhesion barriers market into key market segments.
  • In the next section, the report reveals the important market dynamics and highlights several probable barriers, drivers and trends that will define the size and worth of the market in the years to come.
  • The following sections quantify the analysis of the global surgical hemostats, internal tissue sealants and adhesion barriers market by presenting data on the market size along with key performance metrics.
  • The last part of the report is devoted to a study of the market performance of some of the leading companies operating in the global surgical hemostats, internal tissue sealants and adhesion barriers market.

Global Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers Market: Segmentation

  • By Product Type
    • Hemostats
      • Thrombin Based
      • Combination Hemostats
      • Oxidized Regenerated
      • Cellulose Based
      • Gelatin Based
      • Collagen Based
    • Tissue Sealants
      • Fibrin Based
      • Collagen Based
      • Protein Based
      • Synthetic Sealants
    • Adhesion Barriers
      • Film Based
      • Gel Based
      • Solution Based
  • By Application
    • Surgical Repair
      • Cardiovascular
      • Neurological
      • Orthopaedic
      • Urological
      • General Surgeries
      • Reconstructive Surgeries
    • Trauma Cases
  • By End User
    • Hospitals
    • Ambulatory Surgical Centers
    • Specialty Clinics
  • By Region
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East and Africa

A systematic research approach

Persistence Market Research performs systematic and exhaustive secondary research to analyze the required data points to arrive at the overall market numbers. The research team has developed a list of market players across the value chain (technology developers, manufacturers, distributors, etc.) and conducted extensive one-on-one interviews of key stakeholders to understand each node in the value chain to fetch the required market information. The massive pool of data accumulated through primary and secondary research is validated through triangulation method and scrutinized by a special tool to obtain the qualitative and quantitative insights about the industry.

Key metrics

The report on the global surgical hemostats, internal tissue sealants and adhesion barriers market encapsulates the key metrics that accurately describe the global surgical hemostats, internal tissue sealants and adhesion barriers market and this data has been used to compare market performance across the various segments and regions. Apart from estimating the compound annual growth rate (CAGR) of the global surgical hemostats, internal tissue sealants and adhesion barriers market, the report analyzes Y-O-Y growth to understand the market predictability and to identify the right opportunities likely to emerge in this market. The analysts have also studied the BPS (Basis Point Share) to gauge the overall contribution of individual segments to market growth. The report further analyzes the revenue forecasts in terms of absolute dollar opportunity. A unique market attractiveness index is also developed to understand the current and future opportunities across the global surgical hemostats, internal tissue sealants and adhesion barriers market.

North America to play a pivotal role in the expansion of the global surgical hemostats, internal tissue sealants and adhesion barriers market within the period of forecast

The global surgical hemostats, internal tissue sealants and adhesion barriers market is expected to register a CAGR of 8.7% within the period of forecast (2016 – 2024). In terms of revenue, the hemostats segment dominated the global market in 2015 but is expected to lose its share to the internal tissue sealants segment gradually over the forecast period. The rapid adoption of second generation platelet rich tissue sealants acting both as hemostat and sealant and also supporting tissue regeneration are likely to impact market share adversely. The North America region dominated the market in 2015. An increasing number of surgical procedures in the region, rapid product launches and expansion of product indication are the main factors driving the growth of the hemostats, internal tissue sealants and adhesion barriers market in North America.

Global surgical hemostats, internal tissue sealants and adhesion barriers market – analytical study of regional market performance

The North America region is expected to dominate the market throughout the assessment period and is expected to represent an incremental dollar opportunity of more than US$ 1630 Mn within the forecast period. The market is forecasted to grow between US$ 107.6 Mn and US$ 249.1 Mn annually over 2016–2024. North America is expected to be the most attractive market partly due to a high penetration rate of tissue sealants and adhesion barrier products in the region. The Europe surgical hemostats, internal tissue sealants and adhesion barriers market is expected to give a tough fight to the North America surgical hemostats, internal tissue sealants and adhesion barriers market within the period of forecast. A swelling number of local and regional players in the Europe market is likely to create a favorable climate for growth of the regional market. Moreover, distribution contracts between global and local players would drive the growth of the Europe surgical hemostats, internal tissue sealants and adhesion barriers market. APAC is likely to reserve its berth amongst the top contenders within the forecast period. Low pace of research and development activities in the region is likely to impact the development of the surgical hemostats, internal tissue sealants and adhesion barriers market in MEA and Latin America regions.

North America to continue its growth run within the forecast period

U.S. is expected to be the fastest growing market in the North America surgical hemostats, internal tissue sealants and adhesion barriers market. The U.S market crossed a value of more than US$ 1025 Mn in 2015 and it is expected to soar above US$ 2300 Mn by the end of 2024. The market will record a CAGR of 10.0% during the assessment period. Tissue sealants are being used in the U.S. for a wide array of applications, with fibrin sealants having a penetration rate of 25% -30% in orthopedic surgeries. The Canada surgical hemostats, internal tissue sealants and adhesion barriers market is expected to grow at a CAGR of 8.3% over the forecast period. Increasing adoption of hemostats in the treatment of trauma cases in Canada would drive the growth of the surgical hemostats, internal tissue sealants and adhesion barriers market in the region.

surgical hemostat tissue sealants and adhesion barrier market

All segments to showcase significant growth in the North America region

  • By product type, the hemostats segment dominated the North America surgical hemostats, internal tissue sealants and adhesion barriers market in terms of revenue in 2015 and is projected to continue to do so throughout the forecast period. However, tissue sealants being the fastest growing segment is expected to be the most lucrative.
  • By application, the surgical repair segment is expected to be the most lucrative with a market attractiveness index of 1.3. Cardiovascular surgeries and orthopedic surgeries are the fastest growing application areas for surgical hemostats, internal tissue sealants and adhesion barrier products. Even though many fibrin sealants received late approvals for cardiovascular surgeries in the U.S, these products are being employed in the country for emergency procedures.
  • By end user, the hospitals segment is the most lucrative segment with a market attractiveness index of 2.2.

Company Profiles

  • Ethicon (Johnson & Johnson)
  • Baxter International Inc.
  • Integra LifeSciences Holdings Corporation
  • Pfizer Inc.
  • Tissuemed Ltd.
  • Sanofi
  • Braun Melsungen AG
  • C.R. Bard, Inc.
  • CryoLife, Inc.
  • Cohera Medical, Inc.
  • CSL Behring
  • Others
Back To Top